ÂÜÀòÂÒÂ×

Andrew Germain is a seasoned legal professional specializing in intellectual property, currently serving as Vice President of Legal at Foghorn Therapeutics Inc. since June 2020, after previously holding the position of Senior Director of Intellectual Property. Prior to this role, Andrew worked as a Patent Attorney and Patent Agent at Clark+Elbing LLP from January 2013 to June 2020 and was an Organic Synthesis Fellow in Medicinal Chemistry at the Broad Institute from July 2009 to January 2013. Andrew's academic background includes a Ph.D. in Chemistry from Boston University and a Bachelor of Arts in Chemistry from the College of the Holy Cross.